It’s a summer Saturday morning and more than 160 people are packed into a windowless classroom beneath a Lower Manhattan street. Organizers had distributed the ad for the three-hour event just three weeks earlier. The goal was to gather people who identify as “Asian” on the U.S. census—and nearly everyone in the overcapacity room fits that label.
Attendees, the flyer says, will learn about precision medicine—a health care trend in which treatment and medication are tailored to an individual’s genes, environment and lifestyle. “Why is it that we’re all getting the same blood pressure pill, when it might work really well with one person and not the other?” event leader Colleen Leners asks the audience. Leners is the policy director for the American Association of Colleges of Nursing. Since mid-May she has been traveling across the country to lead enrollment efforts for a new federal governmentresearch project that is grounded in genetics and aims to overhaul the way health care is delivered.